CJC-1295 with DAC

CJC-1295 with DAC – Long-Acting GHRH Analogue Research Peptide

Short Description: CJC-1295 with DAC is a long-acting GHRH analogue studied for its extended stimulation of GH and IGF-1 release via GHRH receptor activation in in-vitro research.

CJC-1295 with DAC is a synthetic Growth Hormone–Releasing Hormone (GHRH) analogue modified with a Drug Affinity Complex (DAC) to significantly prolong its half-life. In laboratory studies, this peptide is used to investigate the sustained stimulation of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) through interaction with GHRH receptors.

This peptide is produced in accordance with strict laboratory standards and verified via High-Performance Liquid Chromatography (HPLC) to ensure a purity of ≥99%. It is supplied in a stable lyophilized form for use in controlled endocrinological and biochemical research applications.

Key Specifications

• Name: CJC-1295 with DAC (Drug Affinity Complex)

• Molecular Formula: C165H271N47O46

• Molecular Weight: ≈ 3647.1 Da

• Form: Lyophilized Powder

• Purity: ≥99% (HPLC tested)

• Storage: Store refrigerated, protected from light and moisture

Research Applications & Benefits

• Studied for long-term stimulation of GH and IGF-1 secretion.

• Relevant for in-vitro endocrinological and receptor signaling research.

• Extended half-life supports investigations of growth hormone regulation.

• Lyophilized format allows for stable storage and precise laboratory handling.

For research use only. Not for human or veterinary consumption.